Dosing

Results: 349



#Item
31Radiobiology / Radioactivity / Physics / Medicine / Nuclear physics / Radiation therapy / Ionizing radiation / Radiation / Glioblastoma / Gray / Absorbed dose

J. Math. Biol. DOIs00285x Mathematical Biology Optimization of radiation dosing schedules

Add to Reading List

Source URL: michorlab.dfci.harvard.edu

Language: English - Date: 2015-06-25 14:34:25
32

description of simvastatin. ezetimibe plus simvastatin, simvastatin amlodipine simvastatin sideeffects does simvastatin remove plaque simvastatin weekly dosing, inergy simvastatin and ezetimibe, withdrawal of simvastatin

Add to Reading List

Source URL: upsizemag.com

Language: English - Date: 2016-06-19 07:37:12
    33Chemistry / Organic chemistry / Quinazolines / Amines / Alkynes / Erlotinib / Ethers / Pfizer / Gefitinib / Epidermal growth factor receptor / Genentech / Pancreatic cancer

    erlotinib smpc erlotinib egfr, erlotinib hydrochloride cancer treatment erlotinib, tarceva erlotinib erlotinib dosing erlotinib tarceva fda erlotinib supplemental, lung ca erlotinib. clarke g and erlotinib

    Add to Reading List

    Source URL: pulseseismic.com

    Language: English - Date: 2016-06-18 06:46:08
    34

    aldactone for hypokalemia aldactone and urine order progesterone aldactone aldactone give to infants. aldactone dosing aldactone cystic acne aldactone long menses

    Add to Reading List

    Source URL: www.naturaldiamondcompany.com

    Language: English - Date: 2016-06-18 03:47:10
      35Radiobiology / Brain tumor / Medicine / Health / Biology / RTT / Radioactivity / Medical physics / Radiation therapy / Glioblastoma multiforme / Glioma / Radioresistance

      Mathematical Modeling of PDGF-Driven Glioblastoma Reveals Optimized Radiation Dosing Schedules

      Add to Reading List

      Source URL: michorlab.dfci.harvard.edu

      Language: English - Date: 2014-01-30 11:55:38
      36Quinazolines / Lung cancer / Amines / Tyrosine kinase receptors / Ethers / T790M / Erlotinib / EGFR inhibitors / Epidermal growth factor receptor / Gefitinib / Afatinib / Targeted therapy

      Optimization of Dosing for EGFR-Mutant Non−Small Cell Lung Cancer with Evolutionary Cancer Modeling Juliann Chmielecki, et al. Sci Transl Med 3, 90ra59 (2011); DOI: scitranslmed

      Add to Reading List

      Source URL: michorlab.dfci.harvard.edu

      Language: English - Date: 2011-08-23 09:57:30
      37Medicine / Clinical medicine / Cancer / RTT / Evolutionary biology / Carcinogenesis / Cancer treatments / Oncology / Chemotherapy / Mutation / Cancer stem cell / Erlotinib

      Dose-Dependent Mutation Rates Determine Optimum Erlotinib Dosing Strategies for EGFR Mutant Non-Small Cell Lung Cancer Patients

      Add to Reading List

      Source URL: michorlab.dfci.harvard.edu

      Language: English - Date: 2015-11-13 12:01:16
      38Chemistry / Organic chemistry / Clinical medicine / Amines / Quinazolines / Lung cancer / Ethers / Erlotinib / Pfizer / Gefitinib / Epidermal growth factor receptor / T790M

      ORIGINAL ARTICLE Effects of Pharmacokinetic Processes and Varied Dosing Schedules on the Dynamics of Acquired Resistance to Erlotinib in EGFR-Mutant Lung Cancer Jasmine Foo, PhD,* Juliann Chmielecki, PhD,† William Pao

      Add to Reading List

      Source URL: michorlab.dfci.harvard.edu

      Language: English - Date: 2012-10-16 11:34:15
      39

      The JULABO-lution Today’s reaction applications require not just accurate temperatures but also exact dosing of components, continuous monitoring & analysis, reliable control of parameters and harvesting. This enables

      Add to Reading List

      Source URL: www.julabo.com

      Language: English - Date: 2015-08-17 02:33:07
        40

        Privacy in Pharmacogenetics: An End-to-End Case Study of Personalized Warfarin Dosing Matthew Fredrikson∗ , Eric Lantz∗ , Somesh Jha∗ , Simon Lin† , David Page∗ , Thomas Ristenpart∗ University of Wisconsin∗

        Add to Reading List

        Source URL: rist.tech.cornell.edu

        Language: English - Date: 2015-07-13 21:30:20
          UPDATE